1. Home
  2. CCLD vs TTRX Comparison

CCLD vs TTRX Comparison

Compare CCLD & TTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareCloud Inc.

CCLD

CareCloud Inc.

HOLD

Current Price

$2.38

Market Cap

114.0M

Sector

Technology

ML Signal

HOLD

TTRX

Turn Therapeutics Inc.

N/A

Current Price

$3.69

Market Cap

107.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CCLD
TTRX
Founded
1999
2015
Country
United States
United States
Employees
3650
2
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
114.0M
107.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CCLD
TTRX
Price
$2.38
$3.69
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$8.00
AVG Volume (30 Days)
596.1K
21.7K
Earning Date
05-07-2026
05-31-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$11.49
N/A
Revenue Next Year
$7.95
N/A
P/E Ratio
$32.04
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.95
$2.57
52 Week High
$4.01
$5.98

Technical Indicators

Market Signals
Indicator
CCLD
TTRX
Relative Strength Index (RSI) 31.45 61.38
Support Level $2.22 $3.55
Resistance Level $3.14 $3.83
Average True Range (ATR) 0.17 0.18
MACD -0.07 0.03
Stochastic Oscillator 11.16 84.27

Price Performance

Historical Comparison
CCLD
TTRX

About CCLD CareCloud Inc.

CareCloud Inc delivers flexible, tech-enabled solutions for healthcare providers of all sizes and multi-specialties across the U.S. It is a healthcare technology company offering cloud-based solutions that simplify clinical, administrative, and financial workflows for medical practices of all sizes. Its comprehensive suite includes Electronic Health Records (EHRs), Practice Management, Revenue Cycle Management (RCM), Medical Billing, Telehealth, and Patient Experience solutions. The group helps practices increase efficiency, improve patient care, and drive sustainable growth-all while ensuring HIPAA compliance and seamless integration. The operating segments of the group are Healthcare IT, which is the key revenue-generating segment, and Medical Practice Management.

About TTRX Turn Therapeutics Inc.

Turn Therapeutics Inc is a clinical-stage biotechnology and medical device development company built around its proprietary platform technology called PermaFusion designed to enhance drug performance. The company is developing non-systemic, non-biologic topical immunomodulators for inflammatory skin disease. Its program, GX-03, is being studied for moderate-to-severe eczema based on preclinical evidence of cytokine inhibition and reduced eczema severity, as well as a favorable real-world tolerability record from prior cleared medical device indications for the same formula. GX-03 is currently being evaluated in an ongoing, randomized, double-blind, vehicle-controlled clinical study designed to assess its potential as a topical treatment for moderate-to-severe eczema.

Share on Social Networks: